SURVEYVITALS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) TO DEMOCRATIZE AND ACCELERATE CLINICAL TRIALS
New Global Industry Coalition That Aims to Dramatically Increase Access for All Patients Populations in Clinical Trials and Research Launches Today
– SurveyVitals, Inc. joins an historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The “Decentralized Trials & Research Alliance (DTRA
),” which launches December 10th, 2020, plans to unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and digital-health technologies in decentralized clinical research.
“SurveyVitals is honored to support the founding of the DTRA,” said Blake Vosburgh, President of SurveyVitals. “Decentralized trials, as both a continuity countermeasure and a proactive protocol, create an opportunity for greater patient centricity. By engaging directly with the patient to understand the quality of their experience, the weight of their burden and the detail of the value of the trial to each individual, sponsors and CROs can adapt more quickly to ensure patient retention, inspire protocol adherence and improve future trial design.”
“We are extremely gratified to welcome SurveyVitals to the ‘Decentralized Trials & Research Alliance,’” said Amir Kalali, MD, founder of several collaborative life science communities, and co-convenor of DTRA. “By advancing decentralized research we can make the clinical trial process more patient-focused, increase trial efficiency and encourage use of technologies. We are excited by SurveyVitals’ commitment to embracing decentralized trials and to changing the culture that has been the rate limiter to innovation.”
that COVID-19 may set back non-pandemic clinical trials by several years due to prospective patients’ inability or reluctance to schedule visits at physical research locations. Decentralized approaches to conducting research facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators. Inclusion of representative patient populations in clinical trials by race, age and geographic location has long been an operational challenge. COVID-19 has amplified the disparities and inclusion biases that have become hurdles for potential trial participants.
“Now is the time to share ideas and insights that will chart the future course of clinical trials, accelerating drug development and saving lives – and by taking part in the DTRA, SurveyVitals is demonstrating its leadership to drive change,” said Craig Lipset, DTRA co-convener, clinical innovation advisor, and a pioneer in decentralized trials. “We have a responsibility to advance the health of people with unmet medical needs, and by convening stakeholders from pharma companies, regulators, technology leaders and patient communities, we can remove remaining barriers to adoption and impact patients today.”
SurveyVitals joins with its peer DTRA Member organizations to provide expertise to identify and address gaps and needs and advance best practices through effective education and communication. SurveyVitals urges other organizations interested in taking part to visit DTRA.org
The Decentralized Trials & Research Alliance (DTRA) was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research. It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods. Follow DTRA on Twitter
for more information.
ABOUT SURVEYVITALS, INC:
For over 15 years, SurveyVitals mission has been to partner with healthcare organizations and clinicians to understand and improve the patient experience using innovative technology. In-depth, intuitive reporting tools provide actionable insights in real-time to support data-driven decision making. SurveyVitals offers comprehensive solutions, including a unique blend of digital patient surveys, CMS-approved CAHPS administration, and online reputation tools to help organizations of all sizes and specialties meet their goals. To learn more visit www.SurveyVitals.com
For further information please contact:
Lazar – Finn Partners
For Non-Media Inquiries:
Hope McCain December 10th, 2020 Categories: COVID-19, featured, Patient Experience, Press Release
Tags: clinical trials
, patient experience